Nexalin Technology (NXL) Cash from Financing Activities (2021 - 2026)
Nexalin Technology (NXL) recorded quarterly Cash from Financing Activities of $756421.0 in Q1 2026, up 44.48% quarter-over-quarter from $523550.0 in Q4 2025.
Nexalin Technology (NXL) Cash from Financing Activities (2021 - 2026) Analysis & Trends
Nexalin Technology's Cash from Financing Activities history runs 5 years deep, the most recent figure standing at $756421.0 for Q1 2026.
- In Q1 2026, Cash from Financing Activities changed N/A year-over-year to $756421.0; the TTM figure through Mar 2026 stood at $1.3 million (changed N/A YoY), while the FY2025 annual figure was $5.2 million, up 14.48% from the prior year.
- Cash from Financing Activities was $756421.0 for Q1 2026 at Nexalin Technology, up from $523550.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $8.5 million in Q3 2022 to a low of -$200000.0 in Q1 2023.
- Historically, Cash from Financing Activities has averaged $1.6 million across 4 years, with a median of $261825.0 in 2022.
- Biggest YoY gain for Cash from Financing Activities was 200100.0% in 2023; the steepest drop was 200100.0% in 2023.
- A 4-year view of Cash from Financing Activities shows it stood at $8.5 million in 2022, then sank by 102.35% to -$200000.0 in 2023, then surged by 361.78% to $523550.0 in 2025, then soared by 44.48% to $756421.0 in 2026.
- The last three Cash from Financing Activities figures came in at $756421.0 (Q1 2026), $523550.0 (Q4 2025), and -$200000.0 (Q1 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -451.20 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 21.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | -25.00 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Nexalin Technology | 8.72 Mn | 6.01 Mn | 13,133.00 | 756,421.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 756,421.00 |
| Mar 31, 2026 | 756,421.00 |
| Dec 31, 2025 | 523,550.00 |
| Dec 31, 2025 | 523,550.00 |
| Mar 31, 2023 | -200,000.00 |
| Mar 31, 2023 | -200,000.00 |
| Sep 30, 2022 | 8.52 Mn |
| Sep 30, 2022 | 8.52 Mn |
| Jun 30, 2022 | -5,000.00 |
| Jun 30, 2022 | -5,000.00 |
| Mar 31, 2022 | 100.00 |
| Mar 31, 2022 | 100.00 |
| Dec 31, 2021 | 934,443.00 |
| Dec 31, 2021 | 934,443.00 |